Pediatrics Doctors in Walpole, MA Accepting Medicare

8 Pediatrics doctors found. Showing 1 - 8

Denise R Shiu, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1350 Main St, Walpole, MA 02081 Phone: 508-668-2200    Fax: 508-668-6539

Andrew J Arrison, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1350 Main St, Walpole, MA 02081 Phone: 508-668-2200    Fax: 508-668-6539

Colleen E Ryan, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1350 Main St, Walpole, MA 02081 Phone: 508-668-2200    Fax: 508-668-6539

Frances Ann Orlando, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1350 Main St, Walpole, MA 02081 Phone: 508-668-2200    Fax: 508-668-6539

Rachel Levenson Acker, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1350 Main St, Walpole, MA 02081 Phone: 508-668-2200    Fax: 508-668-6539

Matthew John Feeley, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1350 Main St, Walpole, MA 02081 Phone: 508-668-2200

Peter B Cohn, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1350 Main St, Walpole, MA 02081 Phone: 508-668-2200    Fax: 508-668-6539

Michael A Freiberger, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1350 Main St, Walpole, MA 02081 Phone: 508-668-2200    Fax: 508-668-6539

News Archive

FDA asks Guided Therapeutics to provide additional information on LuViva PMA

Guided Therapeutics, Inc., developer of a rapid and painless biophotonic testing platform for the early detection of cancer, today announced that, after a series of meetings with the U.S. Food and Drug Administration (FDA), and after reviewing draft responses, the FDA has asked the company to provide additional information in the company's response to one remaining question.

Molecular biologists find chink in the armor of Candida, the most common human fungal pathogen

Molecular biologists at Rice University have discovered a key defense mechanism that the yeast Candida albicans uses against attack by the human immune system.

WHO survey highlights how many countries lack funding to deal with health impacts of climate change

Countries have begun to prioritize health in their efforts to protect people from the impact of climate change, but only about a quarter of those recently surveyed by the World Health Organization have been able to fully implement their national health and climate change plans or strategies.

Estrogen use lowered one risk factor for heart disease among some younger postmenopausal women

A follow-up study to the federally funded Women's Health Initiative should help allay one concern in a subset of women in their 50s who are considering taking estrogen to relieve hot flashes.

VistaGen reports successful completion of AV-101 Phase 1 safety study for neuropathic pain

VistaGen Therapeutics, Inc., a stem cell technology company focused on drug discovery and development, today announced the successful completion of its initial Phase 1 safety study of AV-101, the Company's novel orally available prodrug candidate for treatment of neuropathic pain. Neuropathic pain, a serious and chronic condition causing pain after an injury or disease of the peripheral or central nervous system, affects approximately 1.8 million people in the U.S.

Read more Medical News

› Verified 3 days ago